11:15

Current Status of IPV

Carlton Meschievitz, Pasteur Mérieux Connaught

12:15 p.m.

LUNCH

Options for Poliomyelitis Vaccination
 

Chair, Wednesday afternoon session

Russell Alexander, Seattle-King County Health Department

1:15 p.m.

Benefits and Risks: Personal Experiences

March of Dimes Historical Video

John Salamone, Oakton, Virginia

Lenita Schafer, Princeton, Massachusetts

1:40

Oral Poliovirus Vaccine—Benefits, Risks, and What Is Not Known

Peter Wright, Vanderbilt University

2:20

Inactivated Poliovirus Vaccines—Benefits, Risks, and What Is Not Known

Stanley Plotkin, Pasteur Mérieux Connaught

3:00

Sequential Use of IPV and OPV—Benefits, Risks, and What Is Not Known

John Modlin, Dartmouth Medical School

3:50

Parental Choice—Benefits, Risks, and What Is Not Known

Neal Halsey, Johns Hopkins University

4:00

No Vaccine—Benefits, Risks, and What Is Not Known

D. A. Henderson, Johns Hopkins University

4:20

Modelling the Five Options

Robert Kohberger, Lederle-Praxis

Roland Sutter, Centers for Disease Control and Prevention

5:30

ADJOURN



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement